Verrica Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; …

Biotechnology
US, West Chester [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Verrica Pharmaceuticals Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of VRCA's Analysis
CIK: 1660334 CUSIP: 92511W108 ISIN: US92511W1080 LEI: - UEI: -
Secondary Listings
VRCA has no secondary listings inside our databases.